Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Arvinas Inc has a consensus price target of $47.52 based on the ratings of 22 analysts. The high is $95 issued by Oppenheimer on August 9, 2023. The low is $12 issued by Morgan Stanley on March 13, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Morgan Stanley, and Guggenheim on March 14, 2025, March 13, 2025, and March 13, 2025, respectively. With an average price target of $41.67 between HC Wainwright & Co., Morgan Stanley, and Guggenheim, there's an implied 383.93% upside for Arvinas Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/14/2025 | Buy Now | 840.77% | HC Wainwright & Co. | Andrew Fein57% | $81 → $81 | Reiterates | Buy → Buy | Get Alert |
03/13/2025 | Buy Now | 39.37% | Morgan Stanley | Terence Flynn66% | $48 → $12 | Maintains | Equal-Weight | Get Alert |
03/13/2025 | Buy Now | 271.66% | Guggenheim | Michael Schmidt57% | $57 → $32 | Maintains | Buy | Get Alert |
03/12/2025 | Buy Now | 201.97% | Wells Fargo | Derek Archila59% | $60 → $26 | Maintains | Overweight | Get Alert |
03/12/2025 | Buy Now | 132.29% | BMO Capital | Etzer Darout50% | $82 → $20 | Maintains | Outperform | Get Alert |
03/12/2025 | Buy Now | 39.37% | Wedbush | Robert Driscoll45% | $57 → $12 | Downgrade | Outperform → Neutral | Get Alert |
03/12/2025 | Buy Now | 225.2% | B of A Securities | Tazeen Ahmad55% | $54 → $28 | Maintains | Buy | Get Alert |
03/11/2025 | Buy Now | 840.77% | HC Wainwright & Co. | Andrew Fein57% | $81 → $81 | Reiterates | Buy → Buy | Get Alert |
03/07/2025 | Buy Now | 120.67% | Citigroup | Yigal Nochomovitz55% | $28 → $19 | Maintains | Neutral | Get Alert |
02/12/2025 | Buy Now | 422.65% | Oppenheimer | Matthew Biegler36% | $40 → $45 | Maintains | Outperform | Get Alert |
02/12/2025 | Buy Now | 852.38% | BMO Capital | Etzer Darout50% | $88 → $82 | Reiterates | Outperform → Outperform | Get Alert |
02/12/2025 | Buy Now | 562.02% | Guggenheim | Michael Schmidt57% | $57 → $57 | Reiterates | Buy → Buy | Get Alert |
02/12/2025 | Buy Now | 492.33% | Stifel | Bradley Canino40% | $63 → $51 | Maintains | Buy | Get Alert |
02/07/2025 | Buy Now | — | Cantor Fitzgerald | Li Watsek41% | — | Reiterates | Overweight → Overweight | Get Alert |
02/03/2025 | Buy Now | 271.66% | Barclays | Peter Lawson42% | $48 → $32 | Maintains | Overweight | Get Alert |
12/12/2024 | Buy Now | — | Guggenheim | Michael Schmidt57% | — | Reiterates | Buy → Buy | Get Alert |
12/11/2024 | Buy Now | 910.45% | HC Wainwright & Co. | Andrew Fein57% | $87 → $87 | Reiterates | Buy → Buy | Get Alert |
11/20/2024 | Buy Now | 922.07% | BMO Capital | Etzer Darout50% | $90 → $88 | Maintains | Outperform | Get Alert |
11/18/2024 | Buy Now | 538.79% | Stephens & Co. | Sudan Loganathan32% | → $55 | Initiates | → Overweight | Get Alert |
10/31/2024 | Buy Now | 910.45% | HC Wainwright & Co. | Andrew Fein57% | $87 → $87 | Reiterates | Buy → Buy | Get Alert |
10/31/2024 | Buy Now | 364.58% | Oppenheimer | Matthew Biegler36% | $50 → $40 | Maintains | Outperform | Get Alert |
09/09/2024 | Buy Now | — | Cantor Fitzgerald | Li Watsek41% | — | Reiterates | → Overweight | Get Alert |
08/01/2024 | Buy Now | 910.45% | HC Wainwright & Co. | Andrew Fein57% | $87 → $87 | Reiterates | Buy → Buy | Get Alert |
07/31/2024 | Buy Now | 562.02% | Wedbush | Robert Driscoll45% | $57 → $57 | Reiterates | Outperform → Outperform | Get Alert |
07/31/2024 | Buy Now | — | Cantor Fitzgerald | Li Watsek41% | — | Reiterates | → Overweight | Get Alert |
07/31/2024 | Buy Now | 457.49% | Barclays | Peter Lawson42% | $60 → $48 | Maintains | Overweight | Get Alert |
07/31/2024 | Buy Now | 480.72% | Oppenheimer | Matthew Biegler36% | $70 → $50 | Maintains | Outperform | Get Alert |
05/17/2024 | Buy Now | 910.45% | HC Wainwright & Co. | Andrew Fein57% | $87 → $87 | Reiterates | Buy → Buy | Get Alert |
05/09/2024 | Buy Now | 596.86% | Wells Fargo | Derek Archila59% | $63 → $60 | Maintains | Overweight | Get Alert |
05/08/2024 | Buy Now | 562.02% | Wedbush | Robert Driscoll45% | $57 → $52 | Reiterates | Outperform → Outperform | Get Alert |
05/08/2024 | Buy Now | 910.45% | HC Wainwright & Co. | Andrew Fein57% | $87 → $87 | Reiterates | Buy → Buy | Get Alert |
05/08/2024 | Buy Now | 689.78% | Stifel | Bradley Canino40% | $72 → $68 | Maintains | Buy | Get Alert |
04/15/2024 | Buy Now | 910.45% | HC Wainwright & Co. | Andrew Fein57% | $90 → $87 | Maintains | Buy | Get Alert |
04/12/2024 | Buy Now | 910.45% | HC Wainwright & Co. | Andrew Fein57% | $90 → $87 | Maintains | Buy | Get Alert |
03/25/2024 | Buy Now | 654.94% | Truist Securities | Joon Lee78% | → $65 | Reiterates | Buy → Buy | Get Alert |
02/29/2024 | Buy Now | 596.86% | Barclays | Peter Lawson42% | $26 → $60 | Maintains | Overweight | Get Alert |
02/28/2024 | Buy Now | 945.3% | HC Wainwright & Co. | Andrew Fein57% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
02/28/2024 | Buy Now | 945.3% | BMO Capital | Etzer Darout50% | $89 → $90 | Maintains | Outperform | Get Alert |
02/28/2024 | Buy Now | 585.25% | Wedbush | Robert Driscoll45% | $33 → $59 | Maintains | Outperform | Get Alert |
02/28/2024 | Buy Now | 829.15% | Oppenheimer | Matthew Biegler36% | $95 → $80 | Reiterates | Outperform → Outperform | Get Alert |
02/15/2024 | Buy Now | 538.79% | Citigroup | Yigal Nochomovitz55% | $36 → $55 | Downgrade | Buy → Neutral | Get Alert |
02/14/2024 | Buy Now | 538.79% | Citigroup | Yigal Nochomovitz55% | $36 → $55 | Downgrade | Buy → Neutral | Get Alert |
02/01/2024 | Buy Now | 713.01% | Goldman Sachs | Paul Choi57% | → $70 | Initiates | → Buy | Get Alert |
12/19/2023 | Buy Now | 631.71% | Wells Fargo | Derek Archila59% | → $63 | Upgrade | Equal-Weight → Overweight | Get Alert |
12/06/2023 | Buy Now | 364.58% | Jefferies | Akash Tewari45% | $32 → $40 | Upgrade | Hold → Buy | Get Alert |
11/20/2023 | Buy Now | 364.58% | Guggenheim | Michael Schmitz42% | → $40 | Upgrade | Neutral → Buy | Get Alert |
11/13/2023 | Buy Now | 132.29% | Morgan Stanley | Terence Flynn66% | $32 → $20 | Maintains | Equal-Weight | Get Alert |
11/08/2023 | Buy Now | 387.8% | Stifel | Bradley Canino40% | $46 → $42 | Maintains | Buy | Get Alert |
10/24/2023 | Buy Now | 318.12% | Citigroup | Yigal Nochomovitz55% | $72 → $36 | Maintains | Buy | Get Alert |
10/24/2023 | Buy Now | 201.97% | Barclays | Peter Lawson42% | $39 → $26 | Maintains | Overweight | Get Alert |
10/23/2023 | Buy Now | 538.79% | Piper Sandler | Edward Tenthoff52% | $70 → $55 | Maintains | Overweight | Get Alert |
10/23/2023 | Buy Now | 178.75% | Wedbush | Robert Driscoll45% | $27 → $24 | Upgrade | Neutral → Outperform | Get Alert |
09/07/2023 | Buy Now | 713.01% | Cantor Fitzgerald | Li Watsek41% | → $70 | Reiterates | Overweight → Overweight | Get Alert |
08/21/2023 | Buy Now | 736.24% | Citigroup | Yigal Nochomovitz55% | $77 → $72 | Maintains | Buy | Get Alert |
08/16/2023 | Buy Now | 654.94% | Truist Securities | Joon Lee78% | → $65 | Reiterates | Buy → Buy | Get Alert |
08/14/2023 | Buy Now | 271.66% | Morgan Stanley | Terence Flynn66% | $35 → $32 | Maintains | Equal-Weight | Get Alert |
08/09/2023 | Buy Now | 1003.37% | Oppenheimer | Mark Breidenbach46% | → $95 | Reiterates | Outperform → Outperform | Get Alert |
08/09/2023 | Buy Now | 352.96% | Barclays | Peter Lawson42% | $70 → $39 | Maintains | Overweight | Get Alert |
08/09/2023 | Buy Now | 945.3% | HC Wainwright & Co. | Andrew Fein57% | → $90 | Reiterates | Buy → Buy | Get Alert |
06/26/2023 | Buy Now | 1003.37% | Oppenheimer | Mark Breidenbach46% | → $95 | Assumes | → Outperform | Get Alert |
06/09/2023 | Buy Now | 213.59% | Wedbush | Robert Driscoll45% | → $27 | Reiterates | Neutral → Neutral | Get Alert |
06/09/2023 | Buy Now | 945.3% | HC Wainwright & Co. | Andrew Fein57% | → $90 | Reiterates | Buy → Buy | Get Alert |
05/12/2023 | Buy Now | 306.5% | Morgan Stanley | Terence Flynn66% | $38 → $35 | Maintains | Equal-Weight | Get Alert |
05/08/2023 | Buy Now | 1003.37% | Oppenheimer | Mark Breidenbach46% | → $95 | Reiterates | → Outperform | Get Alert |
05/08/2023 | Buy Now | 608.48% | Credit Suisse | Richard Law45% | → $61 | Reiterates | → Outperform | Get Alert |
05/08/2023 | Buy Now | 736.24% | Stifel | Bradley Canino40% | $75 → $72 | Maintains | Buy | Get Alert |
05/08/2023 | Buy Now | 945.3% | HC Wainwright & Co. | Andrew Fein57% | → $90 | Reiterates | → Buy | Get Alert |
02/27/2023 | Buy Now | 318.12% | Morgan Stanley | Terence Flynn66% | $57 → $36 | Maintains | Equal-Weight | Get Alert |
02/24/2023 | Buy Now | 608.48% | Credit Suisse | Richard Law45% | $81 → $61 | Maintains | Outperform | Get Alert |
02/24/2023 | Buy Now | 945.3% | HC Wainwright & Co. | Andrew Fein57% | → $90 | Reiterates | → Buy | Get Alert |
01/31/2023 | Buy Now | 945.3% | Cantor Fitzgerald | Li Watsek41% | → $90 | Reiterates | → Overweight | Get Alert |
01/17/2023 | Buy Now | 654.94% | Truist Securities | Joon Lee78% | $100 → $65 | Maintains | Buy | Get Alert |
01/12/2023 | Buy Now | — | Guggenheim | Michael Schmidt57% | — | Downgrade | Buy → Neutral | Get Alert |
01/03/2023 | Buy Now | 469.11% | Wells Fargo | Derek Archila59% | $83 → $49 | Downgrade | Overweight → Equal-Weight | Get Alert |
12/05/2022 | Buy Now | 736.24% | Citigroup | Yigal Nochomovitz55% | $88 → $72 | Maintains | Buy | Get Alert |
11/23/2022 | Buy Now | 713.01% | Barclays | Peter Lawson42% | $90 → $70 | Maintains | Overweight | Get Alert |
11/23/2022 | Buy Now | 840.77% | Piper Sandler | Edward Tenthoff52% | $76 → $81 | Maintains | Overweight | Get Alert |
11/23/2022 | Buy Now | 713.01% | SVB Leerink | Andrew Berens49% | $74 → $70 | Maintains | Outperform | Get Alert |
11/22/2022 | Buy Now | 759.47% | SVB Leerink | Andrew Berens49% | $89 → $74 | Maintains | Outperform | Get Alert |
11/11/2022 | Buy Now | 562.02% | Morgan Stanley | Terence Flynn66% | $63 → $57 | Maintains | Equal-Weight | Get Alert |
09/09/2022 | Buy Now | 945.3% | Barclays | Peter Lawson42% | → $90 | Initiates | → Overweight | Get Alert |
08/08/2022 | Buy Now | 1084.67% | Oppenheimer | Mark Breidenbach46% | $108 → $102 | Maintains | Outperform | Get Alert |
08/05/2022 | Buy Now | 933.68% | SVB Leerink | Andrew Berens49% | $91 → $89 | Maintains | Outperform | Get Alert |
08/05/2022 | Buy Now | 945.3% | HC Wainwright & Co. | Andrew Fein57% | $135 → $90 | Maintains | Buy | Get Alert |
08/05/2022 | Buy Now | 805.92% | Credit Suisse | Richard Law45% | $98 → $78 | Maintains | Outperform | Get Alert |
06/21/2022 | Buy Now | 387.8% | Jefferies | Akash Tewari45% | → $42 | Initiates | → Hold | Get Alert |
05/24/2022 | Buy Now | 933.68% | Goldman Sachs | Madhu Kumar72% | $111 → $89 | Maintains | Buy | Get Alert |
05/23/2022 | Buy Now | 782.69% | Piper Sandler | Edward Tenthoff52% | $116 → $76 | Maintains | Overweight | Get Alert |
05/20/2022 | Buy Now | 1096.28% | Citigroup | Yigal Nochomovitz55% | $113 → $103 | Maintains | Buy | Get Alert |
05/09/2022 | Buy Now | 643.32% | Morgan Stanley | Terence Flynn66% | $65 → $64 | Maintains | Equal-Weight | Get Alert |
05/09/2022 | Buy Now | — | Wedbush | Robert Driscoll45% | — | Downgrade | Outperform → Neutral | Get Alert |
04/28/2022 | Buy Now | 1107.9% | Credit Suisse | Richard Law45% | → $104 | Initiates | → Outperform | Get Alert |
04/06/2022 | Buy Now | 654.94% | Morgan Stanley | Terence Flynn66% | → $65 | Initiates | → Equal-Weight | Get Alert |
The latest price target for Arvinas (NASDAQ:ARVN) was reported by HC Wainwright & Co. on March 14, 2025. The analyst firm set a price target for $81.00 expecting ARVN to rise to within 12 months (a possible 840.77% upside). 34 analyst firms have reported ratings in the last year.
The latest analyst rating for Arvinas (NASDAQ:ARVN) was provided by HC Wainwright & Co., and Arvinas reiterated their buy rating.
The last upgrade for Arvinas Inc happened on December 19, 2023 when Wells Fargo raised their price target to $63. Wells Fargo previously had an equal-weight for Arvinas Inc.
The last downgrade for Arvinas Inc happened on March 12, 2025 when Wedbush changed their price target from $57 to $12 for Arvinas Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Arvinas, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Arvinas was filed on March 14, 2025 so you should expect the next rating to be made available sometime around March 14, 2026.
While ratings are subjective and will change, the latest Arvinas (ARVN) rating was a reiterated with a price target of $81.00 to $81.00. The current price Arvinas (ARVN) is trading at is $8.61, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.